Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk

Urology - United States
doi 10.1016/j.urology.2016.01.012
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV

Related search

Evaluation of the Decipher Prostate Cancer Classifier to Predict Metastasis and Disease-Specific Mortality From Genomic Analysis of Diagnostic Prostate Needle Biopsy Specimens.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Utilization of Biopsy-Based Genomic Classifier to Predict Distant Metastasis After Definitive Radiation and Short-Course ADT for Intermediate and High-Risk Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2017English

Evaluation of a Genomic Classifier in Radical Prostatectomy Patients With Lymph Node Metastasis

Research and Reports in Urology
Urology
2016English

Risk Factors Affecting Complications Due to Prostate Biopsy

The Bulletin of Urooncology
2019English

Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image-Guided Radiotherapy Without Hormone Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

A Random Forest Classifier Predicts Recurrence Risk in Patients With Ovarian Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Identification of Prostate Cancer Metastasis-Suppressor Genes Using Genomic shRNA Libraries

2008English

Is a Negative Prostate Biopsy a Risk Factor for a Prostate Cancer Related Death?

The Lancet Oncology
Oncology
2017English

MRI Assisted Stereotactic Biopsy (MAST) in Patients With Elevated Prostate Cancer Risk and Previous Negative Biopsy

JOJ Urology & Nephrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy